147 related articles for article (PubMed ID: 20480142)
1. Hip fracture risk in older US adults by treatment eligibility status based on new National Osteoporosis Foundation guidance.
Looker AC; Dawson-Hughes B; Tosteson AN; Johansson H; Kanis JA; Melton LJ
Osteoporos Int; 2011 Feb; 22(2):541-9. PubMed ID: 20480142
[TBL] [Abstract][Full Text] [Related]
2. The potential impact of new National Osteoporosis Foundation guidance on treatment patterns.
Dawson-Hughes B; Looker AC; Tosteson AN; Johansson H; Kanis JA; Melton LJ
Osteoporos Int; 2010 Jan; 21(1):41-52. PubMed ID: 19705046
[TBL] [Abstract][Full Text] [Related]
3. Serum 25-hydroxyvitamin D and hip fracture risk in older U.S. white adults.
Looker AC; Mussolino ME
J Bone Miner Res; 2008 Jan; 23(1):143-50. PubMed ID: 17907920
[TBL] [Abstract][Full Text] [Related]
4. The potential impact of the National Osteoporosis Foundation guidance on treatment eligibility in the USA: an update in NHANES 2005-2008.
Dawson-Hughes B; Looker AC; Tosteson AN; Johansson H; Kanis JA; Melton LJ
Osteoporos Int; 2012 Mar; 23(3):811-20. PubMed ID: 21717247
[TBL] [Abstract][Full Text] [Related]
5. Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA.
Dawson-Hughes B; Tosteson AN; Melton LJ; Baim S; Favus MJ; Khosla S; Lindsay RL;
Osteoporos Int; 2008 Apr; 19(4):449-58. PubMed ID: 18292975
[TBL] [Abstract][Full Text] [Related]
6. Estimates of the proportion of older white men who would be recommended for pharmacologic treatment by the new US National Osteoporosis Foundation guidelines.
Donaldson MG; Cawthon PM; Lui LY; Schousboe JT; Ensrud KE; Taylor BC; Cauley JA; Hillier TA; Dam TT; Curtis JR; Black DM; Bauer DC; Orwoll ES; Cummings SR;
J Bone Miner Res; 2010 Jul; 25(7):1506-11. PubMed ID: 20200971
[TBL] [Abstract][Full Text] [Related]
7. Serum 25-hydroxyvitamin D and risk of major osteoporotic fractures in older U.S. adults.
Looker AC
J Bone Miner Res; 2013 May; 28(5):997-1006. PubMed ID: 23184640
[TBL] [Abstract][Full Text] [Related]
8. Assessing hip fracture risk in a population-based health survey: the NHANES III osteoporosis component.
Looker AC; Harris TB; Wahner HW
Aging (Milano); 1992 Mar; 4(1):53-60. PubMed ID: 1627677
[TBL] [Abstract][Full Text] [Related]
9. Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis.
Kanis JA; Johnell O; Oden A; Jonsson B; De Laet C; Dawson A
Bone; 2000 Nov; 27(5):585-90. PubMed ID: 11062343
[TBL] [Abstract][Full Text] [Related]
10. Milk and other dairy foods and risk of hip fracture in men and women.
Feskanich D; Meyer HE; Fung TT; Bischoff-Ferrari HA; Willett WC
Osteoporos Int; 2018 Feb; 29(2):385-396. PubMed ID: 29075804
[TBL] [Abstract][Full Text] [Related]
11. Estimates of the proportion of older white women who would be recommended for pharmacologic treatment by the new U.S. National Osteoporosis Foundation Guidelines.
Donaldson MG; Cawthon PM; Lui LY; Schousboe JT; Ensrud KE; Taylor BC; Cauley JA; Hillier TA; Black DM; Bauer DC; Cummings SR;
J Bone Miner Res; 2009 Apr; 24(4):675-80. PubMed ID: 19049330
[TBL] [Abstract][Full Text] [Related]
12. Femur neck bone mineral density and fracture risk by age, sex, and race or Hispanic origin in older US adults from NHANES III.
Looker AC
Arch Osteoporos; 2013; 8():141. PubMed ID: 23715737
[TBL] [Abstract][Full Text] [Related]
13. Hemoglobin and hip fracture risk in older non-Hispanic white adults.
Looker AC
Osteoporos Int; 2014 Oct; 25(10):2389-98. PubMed ID: 24938506
[TBL] [Abstract][Full Text] [Related]
14. Depression and hip fracture risk: the NHANES I epidemiologic follow-up study.
Mussolino ME
Public Health Rep; 2005; 120(1):71-5. PubMed ID: 15736334
[TBL] [Abstract][Full Text] [Related]
15. Performance of FRAX in clinical practice according to sex and osteoporosis definitions: the Manitoba BMD registry.
Leslie WD; Majumdar SR; Morin SN; Lix LM; Schousboe JT; Ensrud KE; Johansson H; McCloskey EV; Kanis JA
Osteoporos Int; 2018 Mar; 29(3):759-767. PubMed ID: 29404625
[TBL] [Abstract][Full Text] [Related]
16. Reducing falls and resulting hip fractures among older women.
Stevens JA; Olson S
MMWR Recomm Rep; 2000 Mar; 49(RR-2):3-12. PubMed ID: 15580729
[TBL] [Abstract][Full Text] [Related]
17. Soluble CD14 and fracture risk.
Bethel M; Bůžková P; Fink HA; Robbins JA; Cauley JA; Lee J; Barzilay JI; Jalal DI; Carbone LD
Osteoporos Int; 2016 May; 27(5):1755-63. PubMed ID: 26659065
[TBL] [Abstract][Full Text] [Related]
18. Disparate outcomes from applying U.K. and U.S. osteoporosis treatment guidelines.
Bolland MJ; Grey A
J Clin Endocrinol Metab; 2010 Apr; 95(4):1856-60. PubMed ID: 20147581
[TBL] [Abstract][Full Text] [Related]
19. Protein intake and risk of hip fractures in postmenopausal women and men age 50 and older.
Fung TT; Meyer HE; Willett WC; Feskanich D
Osteoporos Int; 2017 Apr; 28(4):1401-1411. PubMed ID: 28074249
[TBL] [Abstract][Full Text] [Related]
20. Effect of Bisphosphonates on Fracture Outcomes Among Frail Older Adults.
Zullo AR; Zhang T; Lee Y; McConeghy KW; Daiello LA; Kiel DP; Mor V; Berry SD
J Am Geriatr Soc; 2019 Apr; 67(4):768-776. PubMed ID: 30575958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
